Home/Pipeline/ALA-3000

ALA-3000

Treatment‑Resistant Depression

Phase 1Active

Key Facts

Indication
Treatment‑Resistant Depression
Phase
Phase 1
Status
Active
Company

About Alar Pharmaceuticals

Taiwanese biotech delivering long‑acting injectables for CNS and chronic pain via the In‑Relar platform.

View full company profile

Other Treatment‑Resistant Depression Drugs

DrugCompanyPhase
PsilocybinShields PharmaPreclinical